# Guangzhou Hanpu Pharmaceutical Co. Ltd. – FDA Inspection, Jan 25, 2018

Source: https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/d4994f8c-1692-4e93-8724-ee9e297c2f38
Source feed: FDA_Inspections

> FDA inspection 1040600 of Guangzhou Hanpu Pharmaceutical Co. Ltd., January 25, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1040600
- Company Name: Guangzhou Hanpu Pharmaceutical Co. Ltd.
- Inspection Date: 2018-01-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1259306 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/guangzhou-hanpu-pharmaceutical-co-ltd/b3bd1b3e-9e33-4e7c-8c61-3a783e4dd0da)
- FDA Inspection 844182 - 2013-07-19

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/guangzhou-hanpu-pharmaceutical-co-ltd/aa9e3246-019e-49cc-b473-391a75a82fd2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c